semaglutide and pancreatitis risk Dose-dependent associated with GLP-1 agonists Ozempic and Pancreatitis: Can Semaglutide

GLP-1 Receptor Agonists May Lower Risk for Worsening Mental Illness WEDNESDAY, March 25, 2026 -- Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced risk for worsening of anxiety and depression that co-occur with diabetes and obesity, according to a study published in the April issue of The Lancet Psychiatry

T.ZhongF.HeY.et al (2023)

As this imbalance persists, myocardial fibrosis develops, with progressive interstitial collagen deposition that increases stiffness and deepens diastolic dysfunction, setting the stage for heart failure

Colhoun HM, Lingvay I, Brown PM, et al

A new study suggests that the effectiveness of widely used GLP-1 weight-loss drugs may depend strongly on consistent use

Youll need a new prescription You wont be able to automatically switch from Rybelsus to the Ozempic pill